P. Bhatt Padmanabh's Insider Trades & SAST Disclosures
P. Bhatt Padmanabh's most recent trade in Supernus Pharmaceuticals Inc was a trade of 575 Common Stock done at an average price of $33.1 . Disclosure was reported to the exchange on March 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern P. Bhatt Padmanabh.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 575 | 12,704 (0%) | 0% | 33.1 | 19,004 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 575 | 13,279 (0%) | 0% | 33.1 | 19,004 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.05 per share. | 05 Mar 2025 | 335 | 13,854 (0%) | 0% | 33.1 | 11,072 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 1,650 | 0 | - | - | Performance Share Units | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 1,650 | 11,799 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 2,500 | - | - | Restricted Stock Unit | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 3,750 | - | - | Restricted Stock Unit | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 14,189 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 1,250 | 12,939 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.15 per share. | 21 Feb 2025 | 860 | 10,939 (0%) | 0% | 39.2 | 33,669 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 750 | 11,689 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 750 | 750 | - | - | Restricted Stock Unit | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,500 | 4,500 | - | - | Restricted Stock Unit | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 39.70 per share. | 04 Feb 2025 | 9,477 | 10,149 (0%) | 0% | 39.7 | 376,237 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.61 per share. | 04 Feb 2025 | 9,477 | 19,626 (0%) | 0% | 29.6 | 280,614 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2025 | 9,477 | 4,250 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2025 | 700 | 13,727 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 2,573 | 10,177 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.61 per share. | 27 Jan 2025 | 2,573 | 12,722 (0%) | 0% | 29.6 | 76,187 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 39.62 per share. | 27 Jan 2025 | 2,573 | 10,149 (0%) | 0% | 39.6 | 101,942 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 1,650 | 1,650 | - | - | Performance Share Units | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 39.62 per share. | 27 Jan 2025 | 700 | 10,149 (0%) | 0% | 39.6 | 27,734 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 700 | 9,477 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.61 per share. | 27 Jan 2025 | 700 | 10,849 (0%) | 0% | 29.6 | 20,727 | Common Stock |
| Supernus Pharmaceuticals Inc | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 36.68 per share. | 03 Dec 2024 | 12,745 | 9,679 (0%) | 0% | 36.7 | 467,487 | Common Stock |
| Supernus Pharmaceuticals Inc | Bhatt P. Padmanabh | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.30 per share. | 03 Dec 2024 | 12,745 | 22,424 (0%) | 0% | 25.3 | 322,449 | Common Stock |
| Supernus Pharmaceuticals Inc | P. Padmanabh Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 12,745 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Bhatt P. Padmanabh | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 8,750 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh Bhatt P. | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.99 per share. | 03 Dec 2024 | 8,750 | 18,429 (0%) | 0% | 24.0 | 209,913 | Common Stock |
| Supernus Pharmaceuticals Inc | P. Bhatt Padmanabh | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 36.68 per share. | 03 Dec 2024 | 8,750 | 9,679 (0%) | 0% | 36.7 | 320,950 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 1,250 | 0 | - | - | Performance Share Unit | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 1,250 | 10,251 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.57 per share. | 20 Aug 2024 | 572 | 9,679 (0%) | 0% | 29.6 | 16,914 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 1,250 | 1,250 | - | - | Performance Share Unit | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 35.31 per share. | 21 Mar 2024 | 14,491 | 8,570 (0%) | 0% | 35.3 | 511,677 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2024 | 14,491 | 12,745 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.30 per share. | 21 Mar 2024 | 14,491 | 23,061 (0%) | 0% | 25.3 | 366,622 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 400 | 27,236 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 35.31 per share. | 20 Mar 2024 | 400 | 8,570 (0%) | 0% | 35.3 | 14,124 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.30 per share. | 20 Mar 2024 | 400 | 8,970 (0%) | 0% | 25.3 | 10,120 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.30 per share. | 19 Mar 2024 | 12,364 | 20,934 (0%) | 0% | 25.3 | 312,809 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2024 | 12,364 | 27,636 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 35.31 per share. | 19 Mar 2024 | 12,364 | 8,570 (0%) | 0% | 35.3 | 436,573 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 36,116 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 33.48 per share. | 13 Mar 2024 | 36,116 | 8,570 (0%) | 0% | 33.5 | 1,209,164 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.98 per share. | 13 Mar 2024 | 36,116 | 44,686 (0%) | 0% | 13.0 | 468,786 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.99 per share. | 13 Mar 2024 | 26,250 | 34,820 (0%) | 0% | 24.0 | 629,738 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 26,250 | 8,750 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 34.10 per share. | 13 Mar 2024 | 26,250 | 8,570 (0%) | 0% | 34.1 | 895,125 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.98 per share. | 12 Mar 2024 | 3,884 | 12,454 (0%) | 0% | 13.0 | 50,414 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 3,884 | 36,116 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 32.99 per share. | 12 Mar 2024 | 3,884 | 8,570 (0%) | 0% | 33.0 | 128,133 | Common Stock |
| Supernus Pharmaceuticals Inc | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 5,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | P. Bhatt Padmanabh | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 26 Feb 2024 | 5,000 | 13,570 (0%) | 0% | 9.1 | 45,650 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh Bhatt P. | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 30.21 per share. | 26 Feb 2024 | 5,000 | 8,570 (0%) | 0% | 30.2 | 151,050 | Common Stock |
| Supernus Pharmaceuticals Inc | Bhatt P. Padmanabh | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2024 | 1,250 | 3,750 | - | - | Restricted Stock Unit | |
| Supernus Pharmaceuticals Inc | P. Bhatt Padmanabh | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 1,250 | 9,208 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharmaceuticals Inc | Padmanabh Bhatt P. | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.06 per share. | 23 Feb 2024 | 638 | 8,570 (0%) | 0% | 29.1 | 18,540 | Common Stock |
| Supernus Pharmaceuticals Inc | P. Bhatt Padmanabh | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | P. Padmanabh Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,000 | 5,000 | - | - | Restricted Stock Unit | |
| Supernus Pharmaceuticals Inc | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2024 | 750 | 1,500 | - | - | Restricted Stock Unit | |
| Supernus Pharmaceuticals Inc | Padmanabh Bhatt P. | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 750 | 8,330 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharmaceuticals Inc | P. Padmanabh Bhatt | Sr. VP of IP, CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.94 per share. | 22 Feb 2024 | 372 | 7,958 (0%) | 0% | 27.9 | 10,394 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 2,500 | 2,500 | - | - | Performance Share Unit | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 750 | 5,497 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 750 | 0 | - | - | Performance Share Unit | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 750 | 750 | - | - | Performance Share Unit | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2023 | 1,500 | 4,747 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 750 | 2,250 | - | - | Restricted Stock Units | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 750 | 3,247 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 39.92 per share. | 17 Jan 2023 | 4,826 | 1,644 (0%) | 0% | 39.9 | 192,638 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 4,826 | 5,000 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 17 Jan 2023 | 4,826 | 6,470 (0%) | 0% | 9.1 | 44,061 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 174 | 9,826 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 06 Jan 2023 | 174 | 1,818 (0%) | 0% | 9.1 | 1,589 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 39.90 per share. | 06 Jan 2023 | 174 | 1,644 (0%) | 0% | 39.9 | 6,943 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 37.48 per share. | 01 Dec 2022 | 5,000 | 1,644 (0%) | 0% | 37.5 | 187,416 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 5,000 | 10,000 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 01 Dec 2022 | 5,000 | 6,644 (0%) | 0% | 9.1 | 45,650 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 34.95 per share. | 11 Nov 2022 | 6,800 | 1,644 (0%) | 0% | 34.9 | 237,655 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2022 | 6,800 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.24 per share. | 11 Nov 2022 | 6,800 | 8,444 (0%) | 0% | 9.2 | 62,832 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sale of securities on an exchange or to another person at price $ 34.97 per share. | 09 Nov 2022 | 700 | 1,644 (0%) | 0% | 35.0 | 24,480 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2022 | 700 | 6,800 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.24 per share. | 09 Nov 2022 | 700 | 2,344 (0%) | 0% | 9.2 | 6,468 | Common Stock |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 750 | 1,644 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 18,000 | 18,000 | - | - | Employee Stock Option (Right to Buy) | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 3,000 | 3,000 | - | - | Restricted Stock Units | |
| Supernus Pharmaceuticals Inc | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 17,000 | 17,000 | - | - | Employee Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges